Ross Thomas M.
SEC CIK 1874572 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | EVP, Gbl Sales, Marketing | 42.9K | — | $3.12M | 25 | 2021-11-12 | 2024-08-01 |
Most active insiders at MXCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Swirsky Douglas J | CFO | — | $8,316 |
| 2 | Ahuja Parmeet | CFO | — | — |
| 3 | Johnston John Joseph | Dir | — | — |
| 4 | Masoud Maher | Pres, CEO, Dir | — | — |
| 5 | Hemrajani Rekha | Dir | — | — |
| 6 | Al-Wakeel Yasir B. | Dir | — | — |
| 7 | Brooke William W | Dir | — | — |
| 8 | Collins Cynthia | Dir | — | — |
| 9 | Erck Stanley C | Dir | — | — |
| 10 | BALTHROP PATRICK J | Dir | — | — |
Ross Thomas M. made no open-market trades at MXCT in the last 12 months.
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-05 | 2024-08-01+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl SALES | M - OptEx | $1.64 | +33.3K | 42.9K | +350% | +$54.7K |
| DM | 2024-08-05 | 2024-08-01+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl SALES | S - Sale+OE | $4.44 | -33.3K | 25.0K | -57% | -$148.1K |
| DM | 2024-07-10 | 2024-07-08+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl SALES | S - Sale+OE | $4.03 | -33.3K | 25.0K | -57% | -$134.3K |
| DM | 2024-07-10 | 2024-07-08+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl SALES | M - OptEx | $1.64 | +33.3K | 38.5K | +641% | +$54.7K |
| D | 2024-06-24 | 2024-06-20 | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl SALES | S - Sale+OE | $4.09 | -33.3K | 25.0K | -57% | -$136.3K |
| D | 2024-06-24 | 2024-06-20 | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl SALES | M - OptEx | $1.64 | +33.3K | 58.3K | +133% | +$54.7K |
| D | 2024-03-19 | 2024-03-15 | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl SALES, MARKETING | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
| DM | 2023-04-12 | 2023-04-10+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $5.00 | -14.1K | 0 | -100% | -$70.7K |
| DM | 2023-04-12 | 2023-04-10+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $2.14 | +14.1K | 100 | New | +$30.2K |
| DM | 2023-04-07 | 2023-04-05+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $2.14 | +34.2K | 27.2K | New | +$73.1K |
| DM | 2023-04-07 | 2023-04-05+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $5.02 | -34.2K | 0 | -100% | -$171.6K |
| DM | 2023-04-04 | 2023-03-31+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $5.02 | -9,973 | 0 | -100% | -$50.1K |
| DM | 2023-04-04 | 2023-03-31+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $2.14 | +9,973 | 100 | New | +$21.3K |
| DM | 2023-02-03 | 2023-02-01+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $2.04 | +29.1K | 2,468 | New | +$59.5K |
| DM | 2023-02-03 | 2023-02-01+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $5.72 | -29.1K | 0 | -100% | -$166.5K |
| DM | 2023-01-05 | 2023-01-03+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $0.98 | +29.1K | 9,467 | New | +$28.6K |
| DM | 2023-01-05 | 2023-01-03+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $5.08 | -29.1K | 0 | -100% | -$148.1K |
| DM | 2022-12-06 | 2022-12-02+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $1.08 | +29.1K | 15.0K | New | +$31.5K |
| DM | 2022-12-06 | 2022-12-02+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $5.81 | -29.1K | 0 | -100% | -$169.3K |
| DM | 2022-11-03 | 2022-11-01+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $0.8504 | +29.1K | 23.4K | New | +$24.8K |
| DM | 2022-11-03 | 2022-11-01+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $6.92 | -29.1K | 0 | -100% | -$201.7K |
| DM | 2022-10-12 | 2022-10-10+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $0.84 | +29.1K | 4,282 | New | +$24.5K |
| DM | 2022-10-12 | 2022-10-10+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $6.46 | -29.1K | 0 | -100% | -$188.2K |
| DM | 2021-11-16 | 2021-11-12+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales | M - OptEx | $0.84 | +125.1K | 31.2K | New | +$105.1K |
| DM | 2021-11-16 | 2021-11-12+ | MXCT | MAXCYTE, INC. | Ross Thomas M. | EVP, Gbl Sales | S - Sale+OE | $12.31 | -125.1K | 0 | -100% | -$1.54M |
Purchase Sale Sale after option exercise All abbreviations